Jane Street’s Palisade Bio PALI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$719K Buy
410,761
+67,075
+20% +$122K ﹤0.01% 7224
2025
Q4
$808K Buy
+343,686
New +$661K ﹤0.01% 6591
2022
Q2
Sell
-48
Closed -$38K 10536
2022
Q1
$38K Buy
48
+18
+60% +$14.5K ﹤0.01% 9769
2021
Q4
$29K Buy
+30
New +$52.4K ﹤0.01% 9704
2018
Q1
Hold
0
-$39K 5242
2017
Q4
Hold
0
4444
2015
Q3
Hold
0
-$72K 3998
2015
Q2
Hold
0
3485
2014
Q4
Hold
0
-$33K 2880
2014
Q3
Hold
0
2447
2014
Q2
Hold
0
1158
2014
Q1
Hold
0
803

Other funds holding PALI

Jane Street's PALI Position: Q1 2026 in Review

Jane Street increased its Palisade Bio (PALI) stake by 20% in Q1 2026, buying an estimated $122K and bringing the position to 410,761 shares worth $719K. The position accounts for ﹤0.01% of the portfolio, ranked #7224.

Jane Street first reported a position in PALI in Q4 2021 and has held it in 4 quarters since. The position peaked at $808K in Q4 2025. 96 funds tracked by Wall St. Rank hold PALI as of Q1 2026.

  • Jane Street held 410,761 shares of Palisade Bio worth $719K as of Q1 2026.
  • Jane Street bought 67,075 Palisade Bio shares in Q1 2026, an estimated $122K.
  • Palisade Bio made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #7224 holding.
  • Jane Street first reported a position in Palisade Bio in Q4 2021 and has held it in 4 quarters since.
  • Jane Street's Palisade Bio position peaked at $808K in Q4 2025.
  • 96 funds tracked by Wall St. Rank held Palisade Bio as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.